Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ye Guo

Showing results (181-190 of 436) with videos related to

Pageof 44
Sort By:
Therapeutic Advances in Medical Oncology|August 4, 2022
Efficacy and safety of selpercatinib in Chinese patients with advanced <i>RET</i> fusion-positive non-small-cell lung cancer: a phase II clinical trial (LIBRETTO-321)Shun Lu, Ying Cheng, Dingzhi Huang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|October 21, 2009
[Analysis of cells in Tel/aml-1 positive childhood acute lymphoblastic leukemia by two-dimensional gel electrophoresis]Ye Guo, Bao-Li Fan, Yu-Mei Chen, et al.
Vaccine|March 3, 2018
Attenuation, safety, and efficacy of a QX-like infectious bronchitis virus serotype vaccineShihong Yan, Jing Zhao, Deqiong Xie, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 22, 2015
Establishment and development of the personalized criteria for microscopic review following multiple automated routine urinalysis systemsJuan Du, Jia Xu, Fei Wang, et al.
Medical Oncology (Northwood, London, England)|May 29, 2010
Clinical features and treatment outcomes of 14 cases of primary ovarian non-Hodgkin's lymphoma: a single-center experienceXiao-Ying Zhao, Xiao-Nan Hong, Jun-Ning Cao, et al.
Cancer Medicine|September 9, 2022
A phase II study of antiangiogenic therapy (Apatinib) plus chemotherapy as second-line treatment in advanced small cell lung cancerYinghui Xu, Xu Wang, Chao Sun, et al.
The Journal of Endocrinology|June 9, 2019
Both insufficient and excessive glucocorticoid receptor-mediated signaling impair neuronal migrationHuali Yu, Ye Guo, Yang Zhao, et al.
Leukemia & Lymphoma|August 12, 2020
Minimal residual disease surveillance at day 90 predicts long-term survival in pediatric patients with T-cell acute lymphoblastic leukemiaXiaoming Liu, Yao Zou, Xiaojuan Chen, et al.
International Journal of Cancer|July 22, 2014
Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancerYujuan Zhang, Fei Wang, Ning Ning, et al.
Pediatric Blood & Cancer|September 2, 2014
CALR mutation screening in pediatric primary myelofibrosisWenbin An, Yang Wan, Ye Guo, et al.
Pageof 44

Showing results (181-190 of 436) with videos related to

Sort By:
Pageof 44
Therapeutic Advances in Medical Oncology|August 4, 2022
Efficacy and safety of selpercatinib in Chinese patients with advanced <i>RET</i> fusion-positive non-small-cell lung cancer: a phase II clinical trial (LIBRETTO-321)Shun Lu, Ying Cheng, Dingzhi Huang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|October 21, 2009
[Analysis of cells in Tel/aml-1 positive childhood acute lymphoblastic leukemia by two-dimensional gel electrophoresis]Ye Guo, Bao-Li Fan, Yu-Mei Chen, et al.
Vaccine|March 3, 2018
Attenuation, safety, and efficacy of a QX-like infectious bronchitis virus serotype vaccineShihong Yan, Jing Zhao, Deqiong Xie, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 22, 2015
Establishment and development of the personalized criteria for microscopic review following multiple automated routine urinalysis systemsJuan Du, Jia Xu, Fei Wang, et al.
Medical Oncology (Northwood, London, England)|May 29, 2010
Clinical features and treatment outcomes of 14 cases of primary ovarian non-Hodgkin's lymphoma: a single-center experienceXiao-Ying Zhao, Xiao-Nan Hong, Jun-Ning Cao, et al.
Cancer Medicine|September 9, 2022
A phase II study of antiangiogenic therapy (Apatinib) plus chemotherapy as second-line treatment in advanced small cell lung cancerYinghui Xu, Xu Wang, Chao Sun, et al.
The Journal of Endocrinology|June 9, 2019
Both insufficient and excessive glucocorticoid receptor-mediated signaling impair neuronal migrationHuali Yu, Ye Guo, Yang Zhao, et al.
Leukemia & Lymphoma|August 12, 2020
Minimal residual disease surveillance at day 90 predicts long-term survival in pediatric patients with T-cell acute lymphoblastic leukemiaXiaoming Liu, Yao Zou, Xiaojuan Chen, et al.
International Journal of Cancer|July 22, 2014
Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancerYujuan Zhang, Fei Wang, Ning Ning, et al.
Pediatric Blood & Cancer|September 2, 2014
CALR mutation screening in pediatric primary myelofibrosisWenbin An, Yang Wan, Ye Guo, et al.
Pageof 44